Delivery Order SPE2DB22D2211-SPE2DB24FMMW0
Award Date 1/4/24
Potential Completion Date 1/5/24
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,731.07, is for the supply of 400 mg/200 mL ropivacaine 0.2% injectable medication. The contract has a firm fixed price pricing type and an ultimate completion date of March 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This is a federal delivery order (contract) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 400 mg/200 mL ropivacaine 0.2% in 200 mL doses, with a ceiling value of $6,449.98 and a completion date of June 18, 2024. The contract is a firm fixed-price delivery order and is not designated as a set-aside. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,558.35, is for the supply of 400 mg/200 mL vials of Ropivacaine 0.2% anesthetic. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This is a $2,665.10 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4566997560 - Ropivacaine 0.2% 400 mg/200 mL 200 mL, with a performance period running through January 22, 2025. This delivery order is placed under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,775.55, is for the delivery of Ropivacaine 0.2% 400 mg/200 ml (200 ml) medical supplies. The contract has an ultimate completion date of May 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 400 mg/200 mL vials of the anesthetic medication ropivacaine 0.2%. The delivery order, valued at $5,194.15, is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 400 mg/200 mL ropivacaine 0.2% injectable medication. The order is valued at $9,108.78 with a completion date of February 1, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distributor that supplies medical products to various federal agencies, including...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,948.16, is for the delivery of 400 mg/200 mL vials of the anesthetic drug Ropivacaine 0.2%. The contract is a Firm Fixed Price Delivery Order with a completion date of June 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,896.03 firm fixed-price contract is for the delivery of 4567829319 - Ropivacaine 0.2% 400 mg/200 ml 200 ml, with a period of performance through April 8, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Ropivacaine 0.2% 400 mg/200 ml medication. The contract has a ceiling value of $1,741.02 and a performance period that runs through April 2, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...